Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 446 entries
Sorted by: Best Match Show Resources per page
BSN completion achievement with style.

Imprint

Ruholl L, Layton S.
PMID: 2767707
Imprint. 1989 Sep T-Oct;36(3):86-91.

No abstract available.

Cite
Ruholl L, Layton S. BSN completion achievement with style. Imprint. 1989;36(3):86-91
Ruholl, L., & Layton, S. (1989). BSN completion achievement with style. Imprint, 36(3), 86-91.
Ruholl, L, and Layton, S. "BSN completion achievement with style." Imprint vol. 36,3 (1989): 86-91.
Ruholl L, Layton S. BSN completion achievement with style. Imprint. 1989 Sep T-Oct;36(3):86-91. PMID: 2767707.
Copy Download .nbib Format: NLM
Funding issues in primary care and family practice: a policy perspective.

The Journal of family practice

Graham R, Lawton S.
PMID: 7276869
J Fam Pract. 1981 Sep;13(4):564-9.

No abstract available.

Cite
Graham R, Lawton S. Funding issues in primary care and family practice: a policy perspective. J Fam Pract. 1981;13(4):564-9
Graham, R., & Lawton, S. (1981). Funding issues in primary care and family practice: a policy perspective. The Journal of family practice, 13(4), 564-9.
Graham, R, and Lawton, S. "Funding issues in primary care and family practice: a policy perspective." The Journal of family practice vol. 13,4 (1981): 564-9.
Graham R, Lawton S. Funding issues in primary care and family practice: a policy perspective. J Fam Pract. 1981 Sep;13(4):564-9. PMID: 7276869.
Copy Download .nbib Format: NLM
Building Better Environmental Risk Assessments.

Frontiers in bioengineering and biotechnology

Layton R, Smith J, Macdonald P, Letchumanan R, Keese P, Lema M.
PMID: 26301217
Front Bioeng Biotechnol. 2015 Aug 06;3:110. doi: 10.3389/fbioe.2015.00110. eCollection 2015.

Risk assessment is a reasoned, structured approach to address uncertainty based on scientific and technical evidence. It forms the foundation for regulatory decision-making, which is bound by legislative and policy requirements, as well as the need for making timely...

Cite
Layton R, Smith J, Macdonald P, et al. Building Better Environmental Risk Assessments. Front Bioeng Biotechnol. 2015;3:110doi: 10.3389/fbioe.2015.00110.
Layton, R., Smith, J., Macdonald, P., Letchumanan, R., Keese, P., & Lema, M. (2015). Building Better Environmental Risk Assessments. Frontiers in bioengineering and biotechnology, 3110. https://doi.org/10.3389/fbioe.2015.00110
Layton, Raymond, et al. "Building Better Environmental Risk Assessments." Frontiers in bioengineering and biotechnology vol. 3 (2015): 110. doi: https://doi.org/10.3389/fbioe.2015.00110
Layton R, Smith J, Macdonald P, Letchumanan R, Keese P, Lema M. Building Better Environmental Risk Assessments. Front Bioeng Biotechnol. 2015 Aug 06;3:110. doi: 10.3389/fbioe.2015.00110. eCollection 2015. PMID: 26301217; PMCID: PMC4526797.
Copy Download .nbib Format: NLM
Enhanced Size Selection in Two-Photon Excitation for CsPbBr.

The journal of physical chemistry letters

Chen J, Chábera P, Pascher T, Messing ME, Schaller R, Canton S, Zheng K, Pullerits T.
PMID: 28975796
J Phys Chem Lett. 2017 Oct 19;8(20):5119-5124. doi: 10.1021/acs.jpclett.7b02178. Epub 2017 Oct 05.

Cesium lead bromide (CsPbBr

Cite
Chen J, Chábera P, Pascher T, et al. Enhanced Size Selection in Two-Photon Excitation for CsPbBr. J Phys Chem Lett. 2017;8(20):5119-5124doi: 10.1021/acs.jpclett.7b02178.
Chen, J., Chábera, P., Pascher, T., Messing, M. E., Schaller, R., Canton, S., Zheng, K., & Pullerits, T. (2017). Enhanced Size Selection in Two-Photon Excitation for CsPbBr. The journal of physical chemistry letters, 8(20), 5119-5124. https://doi.org/10.1021/acs.jpclett.7b02178
Chen, Junsheng, et al. "Enhanced Size Selection in Two-Photon Excitation for CsPbBr." The journal of physical chemistry letters vol. 8,20 (2017): 5119-5124. doi: https://doi.org/10.1021/acs.jpclett.7b02178
Chen J, Chábera P, Pascher T, Messing ME, Schaller R, Canton S, Zheng K, Pullerits T. Enhanced Size Selection in Two-Photon Excitation for CsPbBr. J Phys Chem Lett. 2017 Oct 19;8(20):5119-5124. doi: 10.1021/acs.jpclett.7b02178. Epub 2017 Oct 05. PMID: 28975796.
Copy Download .nbib Format: NLM
Usefulness of positron emission tomography to detect cerebral amyloid as a means to diagnose neurodegenerative disease.

Proceedings (Baylor University. Medical Center)

Page J, Oza U, Layton K, Padilla C.
PMID: 28670089
Proc (Bayl Univ Med Cent). 2017 Jul;30(3):362-364. doi: 10.1080/08998280.2017.11929650.

Alzheimer's disease is characterized histologically by the accumulation of a subtype of amyloid protein-beta amyloid-in the brain parenchyma in the form of amyloid plaques. In another neurodegenerative disorder, cerebral amyloid angiopathy, the accumulation of beta amyloid occurs within the...

Cite
Page J, Oza U, Layton K, et al. Usefulness of positron emission tomography to detect cerebral amyloid as a means to diagnose neurodegenerative disease. Proc (Bayl Univ Med Cent). 2017;30(3):362-364doi: 10.1080/08998280.2017.11929650.
Page, J., Oza, U., Layton, K., & Padilla, C. (2017). Usefulness of positron emission tomography to detect cerebral amyloid as a means to diagnose neurodegenerative disease. Proceedings (Baylor University. Medical Center), 30(3), 362-364. https://doi.org/10.1080/08998280.2017.11929650
Page, Jessica, et al. "Usefulness of positron emission tomography to detect cerebral amyloid as a means to diagnose neurodegenerative disease." Proceedings (Baylor University. Medical Center) vol. 30,3 (2017): 362-364. doi: https://doi.org/10.1080/08998280.2017.11929650
Page J, Oza U, Layton K, Padilla C. Usefulness of positron emission tomography to detect cerebral amyloid as a means to diagnose neurodegenerative disease. Proc (Bayl Univ Med Cent). 2017 Jul;30(3):362-364. doi: 10.1080/08998280.2017.11929650. PMID: 28670089; PMCID: PMC5468047.
Copy Download .nbib Format: NLM
Accelerated Superposition State Molecular Dynamics for Condensed Phase Systems.

Journal of chemical theory and computation

Ceotto M, Ayton GS, Voth GA.
PMID: 26620930
J Chem Theory Comput. 2008 Apr;4(4):560-8. doi: 10.1021/ct7003275.

An extension of superposition state molecular dynamics (SSMD) [Venkatnathan and Voth J. Chem. Theory Comput. 2005, 1, 36] is presented with the goal to accelerate timescales and enable the study of "long-time" phenomena for condensed phase systems. It does...

Cite
Ceotto M, Ayton GS, Voth GA. Accelerated Superposition State Molecular Dynamics for Condensed Phase Systems. J Chem Theory Comput. 2008;4(4):560-8doi: 10.1021/ct7003275.
Ceotto, M., Ayton, G. S., & Voth, G. A. (2008). Accelerated Superposition State Molecular Dynamics for Condensed Phase Systems. Journal of chemical theory and computation, 4(4), 560-8. https://doi.org/10.1021/ct7003275
Ceotto, Michele, et al. "Accelerated Superposition State Molecular Dynamics for Condensed Phase Systems." Journal of chemical theory and computation vol. 4,4 (2008): 560-8. doi: https://doi.org/10.1021/ct7003275
Ceotto M, Ayton GS, Voth GA. Accelerated Superposition State Molecular Dynamics for Condensed Phase Systems. J Chem Theory Comput. 2008 Apr;4(4):560-8. doi: 10.1021/ct7003275. PMID: 26620930.
Copy Download .nbib Format: NLM
Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey.

Dermatology and therapy

Dirschka T, Micali G, Papadopoulos L, Tan J, Layton A, Moore S.
PMID: 26022994
Dermatol Ther (Heidelb). 2015 Jun;5(2):117-27. doi: 10.1007/s13555-015-0077-2. Epub 2015 May 29.

INTRODUCTION: Rosacea (including facial erythema) has a negative impact on psychological and emotional health. This survey aimed to assess the impact of facial erythema on subconscious perceptions and the initial reactions of others and how this affects attitudes in...

Cite
Dirschka T, Micali G, Papadopoulos L, et al. Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey. Dermatol Ther (Heidelb). 2015;5(2):117-27doi: 10.1007/s13555-015-0077-2.
Dirschka, T., Micali, G., Papadopoulos, L., Tan, J., Layton, A., & Moore, S. (2015). Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey. Dermatology and therapy, 5(2), 117-27. https://doi.org/10.1007/s13555-015-0077-2
Dirschka, Thomas, et al. "Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey." Dermatology and therapy vol. 5,2 (2015): 117-27. doi: https://doi.org/10.1007/s13555-015-0077-2
Dirschka T, Micali G, Papadopoulos L, Tan J, Layton A, Moore S. Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey. Dermatol Ther (Heidelb). 2015 Jun;5(2):117-27. doi: 10.1007/s13555-015-0077-2. Epub 2015 May 29. PMID: 26022994; PMCID: PMC4470961.
Copy Download .nbib Format: NLM
Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis.

CPT: pharmacometrics & systems pharmacology

Sahota T, Berges A, Barton S, Cookson L, Zamuner S, Richards D.
PMID: 26225229
CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):e15. doi: 10.1002/psp4.15. Epub 2015 Feb 04.

The amyloid deposits that cause disease in systemic amyloidosis always contain the normal plasma protein, serum amyloid P (SAP) component. SAP is the target of a novel immunotherapy approach now being developed to eliminate amyloid deposits. The treatment is...

Cite
Sahota T, Berges A, Barton S, et al. Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis. CPT Pharmacometrics Syst Pharmacol. 2015;4(2):e15doi: 10.1002/psp4.15.
Sahota, T., Berges, A., Barton, S., Cookson, L., Zamuner, S., & Richards, D. (2015). Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis. CPT: pharmacometrics & systems pharmacology, 4(2), e15. https://doi.org/10.1002/psp4.15
Sahota, T, et al. "Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis." CPT: pharmacometrics & systems pharmacology vol. 4,2 (2015): e15. doi: https://doi.org/10.1002/psp4.15
Sahota T, Berges A, Barton S, Cookson L, Zamuner S, Richards D. Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis. CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):e15. doi: 10.1002/psp4.15. Epub 2015 Feb 04. PMID: 26225229; PMCID: PMC4360666.
Copy Download .nbib Format: NLM
Metabolic acidosis-induced hypercalcemia in an azotemic patient with primary hyperparathyroidism.

Clinical kidney journal

Rastegar M, Levine BS, Felsenfeld AJ.
PMID: 25852894
Clin Kidney J. 2014 Jun;7(3):299-302. doi: 10.1093/ckj/sfu041. Epub 2014 May 09.

A 58-year-old man with Stage 3b chronic kidney disease and primary hyperparathyroidism treated with cinacalcet was admitted for acute cholecystitis. A cholecystostomy tube was placed, estimated glomerular filtration rate decreased, metabolic acidosis developed and ionized calcium increased from 1.33...

Cite
Rastegar M, Levine BS, Felsenfeld AJ. Metabolic acidosis-induced hypercalcemia in an azotemic patient with primary hyperparathyroidism. Clin Kidney J. 2014;7(3):299-302doi: 10.1093/ckj/sfu041.
Rastegar, M., Levine, B. S., & Felsenfeld, A. J. (2014). Metabolic acidosis-induced hypercalcemia in an azotemic patient with primary hyperparathyroidism. Clinical kidney journal, 7(3), 299-302. https://doi.org/10.1093/ckj/sfu041
Rastegar, Mandana, et al. "Metabolic acidosis-induced hypercalcemia in an azotemic patient with primary hyperparathyroidism." Clinical kidney journal vol. 7,3 (2014): 299-302. doi: https://doi.org/10.1093/ckj/sfu041
Rastegar M, Levine BS, Felsenfeld AJ. Metabolic acidosis-induced hypercalcemia in an azotemic patient with primary hyperparathyroidism. Clin Kidney J. 2014 Jun;7(3):299-302. doi: 10.1093/ckj/sfu041. Epub 2014 May 09. PMID: 25852894; PMCID: PMC4377759.
Copy Download .nbib Format: NLM
Viable Compositional Analysis of an Eleven Species Oral Polymicrobial Biofilm.

Frontiers in microbiology

Sherry L, Lappin G, O'Donnell LE, Millhouse E, Millington OR, Bradshaw DJ, Axe AS, Williams C, Nile CJ, Ramage G.
PMID: 27375612
Front Microbiol. 2016 Jun 10;7:912. doi: 10.3389/fmicb.2016.00912. eCollection 2016.

PURPOSE: Polymicrobial biofilms are abundant in clinical disease, particularly within the oral cavity. Creating complex biofilm models that recapitulate the polymicrobiality of oral disease are important in the development of new chemotherapeutic agents. In order to do this accurately...

Cite
Sherry L, Lappin G, O'Donnell LE, et al. Viable Compositional Analysis of an Eleven Species Oral Polymicrobial Biofilm. Front Microbiol. 2016;7:912doi: 10.3389/fmicb.2016.00912.
Sherry, L., Lappin, G., O'Donnell, L. E., Millhouse, E., Millington, O. R., Bradshaw, D. J., Axe, A. S., Williams, C., Nile, C. J., & Ramage, G. (2016). Viable Compositional Analysis of an Eleven Species Oral Polymicrobial Biofilm. Frontiers in microbiology, 7912. https://doi.org/10.3389/fmicb.2016.00912
Sherry, Leighann, et al. "Viable Compositional Analysis of an Eleven Species Oral Polymicrobial Biofilm." Frontiers in microbiology vol. 7 (2016): 912. doi: https://doi.org/10.3389/fmicb.2016.00912
Sherry L, Lappin G, O'Donnell LE, Millhouse E, Millington OR, Bradshaw DJ, Axe AS, Williams C, Nile CJ, Ramage G. Viable Compositional Analysis of an Eleven Species Oral Polymicrobial Biofilm. Front Microbiol. 2016 Jun 10;7:912. doi: 10.3389/fmicb.2016.00912. eCollection 2016. PMID: 27375612; PMCID: PMC4902011.
Copy Download .nbib Format: NLM
Kidney cancer: New AUA guideline tackles follow-up monitoring of small renal masses.

Nature reviews. Urology

Payton S.
PMID: 23712208
Nat Rev Urol. 2013 Jul;10(7):367. doi: 10.1038/nrurol.2013.119. Epub 2013 May 28.

No abstract available.

Cite
Payton S. Kidney cancer: New AUA guideline tackles follow-up monitoring of small renal masses. Nat Rev Urol. 2013;10(7):367doi: 10.1038/nrurol.2013.119.
Payton, S. (2013). Kidney cancer: New AUA guideline tackles follow-up monitoring of small renal masses. Nature reviews. Urology, 10(7), 367. https://doi.org/10.1038/nrurol.2013.119
Payton, Sarah. "Kidney cancer: New AUA guideline tackles follow-up monitoring of small renal masses." Nature reviews. Urology vol. 10,7 (2013): 367. doi: https://doi.org/10.1038/nrurol.2013.119
Payton S. Kidney cancer: New AUA guideline tackles follow-up monitoring of small renal masses. Nat Rev Urol. 2013 Jul;10(7):367. doi: 10.1038/nrurol.2013.119. Epub 2013 May 28. PMID: 23712208.
Copy Download .nbib Format: NLM
Molecular findings from 537 individuals with inherited retinal disease.

Journal of medical genetics

Ellingford JM, Barton S, Bhaskar S, O'Sullivan J, Williams SG, Lamb JA, Panda B, Sergouniotis PI, Gillespie RL, Daiger SP, Hall G, Gale T, Lloyd IC, Bishop PN, Ramsden SC, Black GCM.
PMID: 27208204
J Med Genet. 2016 Nov;53(11):761-767. doi: 10.1136/jmedgenet-2016-103837. Epub 2016 May 11.

BACKGROUND: Inherited retinal diseases (IRDs) are a clinically and genetically heterogeneous set of disorders, for which diagnostic second-generation sequencing (next-generation sequencing, NGS) services have been developed worldwide.METHODS: We present the molecular findings of 537 individuals referred to a 105-gene...

Cite
Ellingford JM, Barton S, Bhaskar S, et al. Molecular findings from 537 individuals with inherited retinal disease. J Med Genet. 2016;53(11):761-767doi: 10.1136/jmedgenet-2016-103837.
Ellingford, J. M., Barton, S., Bhaskar, S., O'Sullivan, J., Williams, S. G., Lamb, J. A., Panda, B., Sergouniotis, P. I., Gillespie, R. L., Daiger, S. P., Hall, G., Gale, T., Lloyd, I. C., Bishop, P. N., Ramsden, S. C., & Black, G. C. M. (2016). Molecular findings from 537 individuals with inherited retinal disease. Journal of medical genetics, 53(11), 761-767. https://doi.org/10.1136/jmedgenet-2016-103837
Ellingford, Jamie M, et al. "Molecular findings from 537 individuals with inherited retinal disease." Journal of medical genetics vol. 53,11 (2016): 761-767. doi: https://doi.org/10.1136/jmedgenet-2016-103837
Ellingford JM, Barton S, Bhaskar S, O'Sullivan J, Williams SG, Lamb JA, Panda B, Sergouniotis PI, Gillespie RL, Daiger SP, Hall G, Gale T, Lloyd IC, Bishop PN, Ramsden SC, Black GCM. Molecular findings from 537 individuals with inherited retinal disease. J Med Genet. 2016 Nov;53(11):761-767. doi: 10.1136/jmedgenet-2016-103837. Epub 2016 May 11. PMID: 27208204; PMCID: PMC5106339.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 446 entries